Ken Fisher’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,000
| Closed | -$33.7K | – | 1068 |
|
|
2025
Q4 | $33.7K | Hold |
10,000
| – | – | ﹤0.01% | 1012 |
|
|
2025
Q3 | $13.1K | Hold |
10,000
| – | – | ﹤0.01% | 1012 |
|
|
2025
Q2 | $7.17K | Buy |
+10,000
| New | +$7.85K | ﹤0.01% | 984 |
|
|
2024
Q2 | – | Sell |
-104,947
| Closed | -$914K | – | 1022 |
|
|
2024
Q1 | $914K | Buy |
104,947
+1,816
| +2% | +$22K | ﹤0.01% | 696 |
|
|
2023
Q4 | $1.18M | Buy |
103,131
+200
| +0.2% | +$1.98K | ﹤0.01% | 663 |
|
|
2023
Q3 | $991K | Buy |
102,931
+26,327
| +34% | +$258K | ﹤0.01% | 743 |
|
|
2023
Q2 | $815K | Buy |
76,604
+186
| +0.2% | +$2K | ﹤0.01% | 813 |
|
|
2023
Q1 | $804K | Buy |
76,418
+1,171
| +2% | +$13.1K | ﹤0.01% | 797 |
|
|
2022
Q4 | $932K | Sell |
75,247
-21,494
| -22% | -$244K | ﹤0.01% | 778 |
|
|
2022
Q3 | $1M | Sell |
96,741
-48,045
| -33% | -$545K | ﹤0.01% | 668 |
|
|
2022
Q2 | $1.67M | Buy |
144,786
+269
| +0.2% | +$3.17K | ﹤0.01% | 554 |
|
|
2022
Q1 | $1.82M | Hold |
144,517
| – | – | ﹤0.01% | 561 |
|
|
2021
Q4 | $1.69M | Buy |
144,517
+58,599
| +68% | +$719K | ﹤0.01% | 583 |
|
|
2021
Q3 | $1.12M | Sell |
85,918
-16,706
| -16% | -$216K | ﹤0.01% | 600 |
|
|
2021
Q2 | $1.32M | Buy |
102,624
+21,106
| +26% | +$242K | ﹤0.01% | 574 |
|
|
2021
Q1 | $911K | Buy |
81,518
+1,329
| +2% | +$14K | ﹤0.01% | 629 |
|
|
2020
Q4 | $913K | Buy |
80,189
+16,657
| +26% | +$182K | ﹤0.01% | 610 |
|
|
2020
Q3 | $571K | Sell |
63,532
-24,989
| -28% | -$248K | ﹤0.01% | 633 |
|
|
2020
Q2 | $914K | Buy |
88,521
+53
| +0.1% | +$542 | ﹤0.01% | 574 |
|
|
2020
Q1 | $893K | Sell |
88,468
-15,812
| -15% | -$186K | ﹤0.01% | 547 |
|
|
2019
Q4 | $1.39M | Sell |
104,280
-113,257
| -52% | -$1.25M | ﹤0.01% | 544 |
|
|
2019
Q3 | $1.87M | Hold |
217,537
| – | – | ﹤0.01% | 549 |
|
|
2019
Q2 | $2.38M | Sell |
217,537
-5,058
| -2% | -$56.7K | ﹤0.01% | 513 |
|
|
2019
Q1 | $2.52M | Sell |
222,595
-4,441
| -2% | -$49.6K | ﹤0.01% | 492 |
|
|
2018
Q4 | $1.97M | Sell |
227,036
-13,160
| -5% | -$151K | ﹤0.01% | 523 |
|
|
2018
Q3 | $3.71M | Sell |
240,196
-12,025
| -5% | -$190K | ﹤0.01% | 455 |
|
|
2018
Q2 | $4.04M | Sell |
252,221
-67,415
| -21% | -$998K | 0.01% | 453 |
|
|
2018
Q1 | $4.13M | Sell |
319,636
-25,686
| -7% | -$320K | 0.01% | 450 |
|
|
2017
Q4 | $4.33M | Buy |
345,322
+105,258
| +44% | +$1.37M | 0.01% | 440 |
|
|
2017
Q3 | $3.17M | Sell |
240,064
-2,139
| -0.9% | -$29.4K | ﹤0.01% | 453 |
|
|
2017
Q2 | $3.83M | Hold |
242,203
| – | – | 0.01% | 407 |
|
|
2017
Q1 | $3.46M | Hold |
242,203
| – | – | 0.01% | 379 |
|
|
2016
Q4 | $3.1M | Sell |
242,203
-47,282
| -16% | -$597K | 0.01% | 385 |
|
|
2016
Q3 | $3.85M | Hold |
289,485
| – | – | 0.01% | 377 |
|
|
2016
Q2 | $3.21M | Buy |
289,485
+8,089
| +3% | +$79K | 0.01% | 412 |
|
|
2016
Q1 | $2.66M | Buy |
+281,396
| New | +$2.32M | 0.01% | 440 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Ken Fisher's IRWD Position: Q1 2026 in Review
Ken Fisher sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 10,000 shares — an estimated $33.7K sold.
Ken Fisher first reported a position in IRWD in Q1 2016 and held it in 36 quarters. The position peaked at $4.33M in Q4 2017. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Ken Fisher reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Ken Fisher sold 10,000 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $33.7K.
- Ken Fisher first reported a position in Ironwood Pharmaceuticals in Q1 2016 and held it in 36 quarters.
- Ken Fisher's Ironwood Pharmaceuticals position peaked at $4.33M in Q4 2017.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.